Journal article · 2026 · Open access

ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury

Dang Hanhan, Kun He, Yulian Zhang, Chuanpeng Zhang, Yunsheng Zhang, Wang Zixi, Xu Yang, Pengyu Chen, Zhan Li, Yanbing Yu

Clinical and Translational Medicine, 16(9), e70845 · Published 1 September 2026 · DOI 10.1002/ctm2.70845

Open full textCite this paper

In brief

“ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury” is a 2026 journal article by Dang Hanhan and 9 co-authors, published in Clinical and Translational Medicine. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Clinical and Translational Medicine.

Citations
0
References
83
Authors
10

Abstract

BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and long-term disability worldwide. Secondary cerebral oedema, driven by neuroinflammation and blood-brain barrier (BBB) disruption, critically determines poor outcomes, yet effective targeted therapies remain absent. This study aimed to identify immune cell subsets associated with post-TBI cerebral oedema and to explore their functional contributions in preclinical models. METHODS: We integrated single-cell transcriptomic datasets from a mouse TBI model (GSE175430) and human intracerebral haemorrhage (ICH) perihaematomal oedema samples (GSE266873) with our previously published temporal bulk RNA-seq profiling data. Through cross-species comparative analysis, Mfuzz clustering, AUCell scoring and gene set enrichment analysis (GSEA), Acp5 was identified as an oedema-associated signature gene, and its macrophage-enriched expression pattern was supported by single-cell profiling and immunofluorescence colocalisation. Using the controlled cortical impact (CCI) model, we validated Acp5 expression dynamics across injury severities. Pharmacological inhibition (AubipyOMe) and genetic knockout of Acp5 were employed to assess brain oedema, neuroinflammation, neurological function and long-term cognitive recovery. RESULTS: A previously unrecognised population of ACP5-positive monocytes/macrophages infiltrated the brain parenchyma within 1-3 days post-injury, coinciding with peak oedema severity and neurological deficits. Inhibiting ACP5 significantly reduced brain water content, BBB leakage and proinflammatory cytokines, while improving sensorimotor function. Mechanistically, ACP5-positive macrophages were associated with CSF2-related JAK/STAT and NF-κB signalling. Genetic Acp5 ablation attenuated acute macrophage infiltration and neuroinflammation, and was associated with improved long-term behavioural outcomes. CONCLUSIONS: ACP5-positive macrophages represent an injury-associated myeloid population that contributes to neuroinflammatory and oedema-related phenotypes after experimental TBI. Pharmacological and genetic findings provide preclinical evidence supporting further investigation of ACP5 and CSF2-related signalling in secondary TBI injury.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hanhan, D., He, K., Zhang, Y., Zhang, C., Zhang, Y., Zixi, W., Yang, X., Chen, P., Li, Z., & Yu, Y. (2026). ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury. Clinical and Translational Medicine, 16(9), e70845. https://doi.org/10.1002/ctm2.70845

MLA 9

Hanhan, Dang, et al. “ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury.” Clinical and Translational Medicine, vol. 16, no. 9, 2026, p. e70845. https://doi.org/10.1002/ctm2.70845.

Chicago

Hanhan, Dang, Kun He, Yulian Zhang, Chuanpeng Zhang, Yunsheng Zhang, Wang Zixi, Xu Yang, Pengyu Chen, Zhan Li, and Yanbing Yu. 2026. “ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury.” Clinical and Translational Medicine 16 (9): e70845. https://doi.org/10.1002/ctm2.70845.

Harvard

Hanhan, D. et al. (2026) ‘ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury’, Clinical and Translational Medicine, 16(9), p. e70845. doi:10.1002/ctm2.70845.

IEEE

D. Hanhan et al., “ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury,” Clinical and Translational Medicine, vol. 16, no. 9, p. e70845, 2026, doi: 10.1002/ctm2.70845.

BibTeX

@article{hanhan2026positive,
  title     = {{ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury}},
  author    = {Hanhan, Dang and He, Kun and Zhang, Yulian and Zhang, Chuanpeng and Zhang, Yunsheng and Zixi, Wang and Yang, Xu and Chen, Pengyu and Li, Zhan and Yu, Yanbing},
  journal   = {Clinical and Translational Medicine},
  year      = {2026},
  volume    = {16},
  number    = {9},
  pages     = {e70845},
  doi       = {10.1002/ctm2.70845},
  url       = {https://doi.org/10.1002/ctm2.70845}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances

  • traumatic brain injury
  • cerebral edema
  • neuroinflammation
  • ACP5
  • macrophages
  • monocytes
  • blood-brain barrier disruption
  • CSF2

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Hanhan, D., He, K., Zhang, Y., Zhang, C., Zhang, Y., Zixi, W., Yang, X., Chen, P., Li, Z., & Yu, Y. (2026). ACP5‐positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury. Clinical and Translational Medicine, 16(9), e70845. https://doi.org/10.1002/ctm2.70845

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical and Translational Medicine: sign in and open the full text from this page.

Who wrote this paper?

Dang Hanhan, Kun He, Yulian Zhang, Chuanpeng Zhang, Yunsheng Zhang, Wang Zixi, Xu Yang, Pengyu Chen, Zhan Li, Yanbing Yu.

What is the DOI of this paper?

10.1002/ctm2.70845, permanently at https://doi.org/10.1002/ctm2.70845. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.